U.S. markets open in 25 minutes

Globus Medical, Inc. (GMED)

NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
61.52-0.78 (-1.25%)
At close: 4:00PM EST

61.50 -0.02 (-0.03%)
Pre-Market: 9:03AM EST

Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bearishpattern detected
MACD

MACD

Previous Close62.30
Open62.04
Bid42.59 x 800
Ask67.50 x 1100
Day's Range61.39 - 62.28
52 Week Range33.41 - 68.24
Volume342,926
Avg. Volume526,215
Market Cap6.134B
Beta (5Y Monthly)0.99
PE Ratio (TTM)60.91
EPS (TTM)1.01
Earnings DateMay 05, 2021 - May 10, 2021
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est71.47
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued
-26% Est. Return
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
View more
  • Globus Medical (GMED) Q4 2020 Earnings Call Transcript
    Motley Fool

    Globus Medical (GMED) Q4 2020 Earnings Call Transcript

    GMED earnings call for the period ending December 31, 2020.

  • Benzinga

    Recap: Globus Medical Q4 Earnings

    Shares of Globus Medical (NYSE:GMED) fell in after-market trading after the company reported Q4 results. Quarterly Results Earnings per share were up 18.37% over the past year to $0.58, which beat the estimate of $0.51. Revenue of $233,445,000 higher by 10.29% from the same period last year, which beat the estimate of $231,220,000. Guidance The upcoming fiscal year's EPS expected to be between $1.83 and $1.83. The upcoming fiscal year's revenue expected to be between $880,000,000 and $880,000,000. Conference Call Details Date: Feb 17, 2021 View more earnings on GMED Time: 04:30 PM ET Webcast URL: https://edge.media-server.com/mmc/p/8oo77asj Price Action 52-week high: $68.24 52-week low: $33.41 Price action over last quarter: Up 27.16% Company Description Globus Medical is a medical device company that develops and provides healthcare products and solutions to hospitals, physicians, and surgical centers. The firm's products are organized into two categories: musculoskeletal solutions, which includes medical devices and instruments used mostly for spinal and orthopedic procedures, and enabling technologies, which includes advanced computer systems developed for enhancing surgical capabilities. The vast majority of the company's revenue is generated from musculoskeletal solutions products, and more than half of the revenue is earned in the United States. See more from BenzingaClick here for options trades from BenzingaEarnings Scheduled For February 17, 2021© 2021 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.